Changes

Jump to navigation Jump to search
no edit summary
Line 17: Line 17:  
| style="padding-right: 0px; padding-left: 0px; padding-bottom: 16px; padding-top: 16px; text-align: center; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif !important;font-size: 11pt;line-height:1.1;font-weight:bold;" width="11%" |<span style="color: #252F38">[[CRI Tools and Resources |Tools and Resources]]</span>
 
| style="padding-right: 0px; padding-left: 0px; padding-bottom: 16px; padding-top: 16px; text-align: center; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif !important;font-size: 11pt;line-height:1.1;font-weight:bold;" width="11%" |<span style="color: #252F38">[[CRI Tools and Resources |Tools and Resources]]</span>
 
|}
 
|}
<div style="background: #ffae42; color:white; font-family:Arial;padding:10px"><span style= "font-size: 10pt">'''We express our gratitude for the overwhelming interest in REEF, and as of January 16, 2024, we are no longer accepting Expressions of Interest for the Regulatory Experimentation Expense Fund.'''</span>
+
<div style="background: #ffae42; color:white; font-family:Arial;padding:10px; text-align:center"><span style="font-size: 10pt">'''We express our gratitude for the overwhelming interest in REEF, and as of January 16, 2024, we are no longer accepting Expressions of Interest for the Regulatory Experimentation Expense Fund.'''</span>
 
</div>
 
</div>
   Line 28: Line 28:     
<p>
 
<p>
*determining whether an experiment would be the right approach (<span style="font-size:14px; color:#538b01; font-weight:bold; font-style:italic;">NEW!</span>)
+
* determining whether an experiment would be the right approach (<span style="font-size:14px; color:#538b01; font-weight:bold; font-style:italic;">NEW!</span>)
 
*developing a regulatory experiment (e.g., scope, evidence needs, experimental process, data collection methods) (<span style="font-size:14px; color:#538b01; font-weight:bold; font-style:italic;">NEW!</span>)
 
*developing a regulatory experiment (e.g., scope, evidence needs, experimental process, data collection methods) (<span style="font-size:14px; color:#538b01; font-weight:bold; font-style:italic;">NEW!</span>)
 
*conducting a regulatory experiment</p>
 
*conducting a regulatory experiment</p>
Line 39: Line 39:  
*technical advice and guidance to help you navigate your specific situation.
 
*technical advice and guidance to help you navigate your specific situation.
    +
<!-- Content to be edited for next REEF cycle
 
='''Interested in applying? Want to learn more?'''=
 
='''Interested in applying? Want to learn more?'''=
 
The first step is to contact the [mailto:cri-cir@tbs-sct.gc.ca?Subject=Regulatory%20Experimentation%20Expense%20Fund%20Enquiry&body=%20 <u>Centre for Regulatory Innovation</u>] to request an informal consultation to determine whether and how the REEF can best support your goals.
 
The first step is to contact the [mailto:cri-cir@tbs-sct.gc.ca?Subject=Regulatory%20Experimentation%20Expense%20Fund%20Enquiry&body=%20 <u>Centre for Regulatory Innovation</u>] to request an informal consultation to determine whether and how the REEF can best support your goals.
    
Several different types of projects have been eligible for the REEF – read more [[CRI Supported Projects|here]].
 
Several different types of projects have been eligible for the REEF – read more [[CRI Supported Projects|here]].
 
+
-->
    
='''The REEF Process'''=
 
='''The REEF Process'''=
Line 61: Line 62:  
<p class="highlighted inline mw-collapsible-content mw-collapsed">The EOI provides a brief overview of the proposed experiment or pre-experimentation project and amount of funding requested. The EOI should not take more than a few hours to complete. If you have questions on how to complete the EOI, it is recommended that you reach out to the CRI. EOIs should be submitted by email to cri-cir@tbs-sct.gc.ca. The CRI will contact applicants as required if clarifications on the proposed experiment or pre-experimentation project are needed.  </p>
 
<p class="highlighted inline mw-collapsible-content mw-collapsed">The EOI provides a brief overview of the proposed experiment or pre-experimentation project and amount of funding requested. The EOI should not take more than a few hours to complete. If you have questions on how to complete the EOI, it is recommended that you reach out to the CRI. EOIs should be submitted by email to cri-cir@tbs-sct.gc.ca. The CRI will contact applicants as required if clarifications on the proposed experiment or pre-experimentation project are needed.  </p>
 
|-
 
|-
|  
+
|
 
=='''Step 3: Proposal Submission'''==
 
=='''Step 3: Proposal Submission'''==
 
|-
 
|-
Line 73: Line 74:  
=='''Step 4: Funding Decision'''==
 
=='''Step 4: Funding Decision'''==
 
|-
 
|-
| Funding will be available from April 2024 upon completion of a MOU with the successful applicant and TBS, and is made available on a cost recovery basis.<p class="highlighted inline mw-collapsible-content"></p>  
+
|Funding will be available from April 2024 upon completion of a MOU with the successful applicant and TBS, and is made available on a cost recovery basis.<p class="highlighted inline mw-collapsible-content"></p>  
    
<p class="highlighted inline mw-collapsible-content mw-collapsed">The department is responsible to forecast their expenses and include the spending schedule in the MOU. The department will be expected to submit scheduled invoices to TBS to recover the expenses incurred as well as submitting financial forecast to allow TBS to decommit the funds that the department no longer plans on recovering.</p><p class="highlighted inline mw-collapsible-content mw-collapsed"></p><p class="highlighted inline mw-collapsible-content mw-collapsed">For more information on each step of the process, please see the [https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwiki.gccollab.ca%2Fimages%2Fd%2Fdd%2FREEF_Guide_-_2022.docx&wdOrigin=BROWSELINK REEF Guide.]</p>
 
<p class="highlighted inline mw-collapsible-content mw-collapsed">The department is responsible to forecast their expenses and include the spending schedule in the MOU. The department will be expected to submit scheduled invoices to TBS to recover the expenses incurred as well as submitting financial forecast to allow TBS to decommit the funds that the department no longer plans on recovering.</p><p class="highlighted inline mw-collapsible-content mw-collapsed"></p><p class="highlighted inline mw-collapsible-content mw-collapsed">For more information on each step of the process, please see the [https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwiki.gccollab.ca%2Fimages%2Fd%2Fdd%2FREEF_Guide_-_2022.docx&wdOrigin=BROWSELINK REEF Guide.]</p>
Line 102: Line 103:  
|Innovation Science and Economic Development (ISED) –  Standards Council of Canada (SCC)
 
|Innovation Science and Economic Development (ISED) –  Standards Council of Canada (SCC)
 
|Piloting an Accreditation Program for the Assessment  of Artificial Intelligence Management Systems (AIMS)
 
|Piloting an Accreditation Program for the Assessment  of Artificial Intelligence Management Systems (AIMS)
|The purpose of this experiment is to pilot a  prototype accreditation program to understand whether the main SCC  Requirements and Guidance document that works in conjunction with ISO/IEC 17021-1:2015 Conformity assessment is clear and appropriate and obtain  feedback from the certification bodies and Artificial Intelligence (AI)  companies about the program. This information is necessary to improve and  refine the prototype.
+
| The purpose of this experiment is to pilot a  prototype accreditation program to understand whether the main SCC  Requirements and Guidance document that works in conjunction with ISO/IEC 17021-1:2015 Conformity assessment is clear and appropriate and obtain  feedback from the certification bodies and Artificial Intelligence (AI)  companies about the program. This information is necessary to improve and  refine the prototype.
    
The SCC is also looking to gather information on whether the AIMS could have  an impact on the level of risk of AI products to inform potential use of AIMS  for regulators.
 
The SCC is also looking to gather information on whether the AIMS could have  an impact on the level of risk of AI products to inform potential use of AIMS  for regulators.
Line 108: Line 109:  
|Transport Canada (TC)
 
|Transport Canada (TC)
 
|Aviation E-Licensing Pilot
 
|Aviation E-Licensing Pilot
|This is a follow up to previous experiment to test a  new QR code prototype with pilots of an air operator within Canada for  effectiveness. The sandbox experiment will test if the digital solution  lowers the cost of compliance and improve compliance with respect to air  operators’ obligation to track employee compliance with licensing  requirements.
+
| This is a follow up to previous experiment to test a  new QR code prototype with pilots of an air operator within Canada for  effectiveness. The sandbox experiment will test if the digital solution  lowers the cost of compliance and improve compliance with respect to air  operators’ obligation to track employee compliance with licensing  requirements.
 
|- bgcolor="#C8D0C1"
 
|- bgcolor="#C8D0C1"
| Health Canada (HC)
+
|Health Canada (HC)
| Machine Learning Enabled Medical Device (MLMD)  Sandbox Development
+
|Machine Learning Enabled Medical Device (MLMD)  Sandbox Development
 
|Health Canada is developing a sandbox to test new regulatory approach for MLMDs. Currently, MLMD can be marketed in Canada if  the device algorithm behaviour is locked to remain the same overtime as what  was presented in the product’s market authorization application. Any change  to the algorithm behaviour requires the submission of an amendment to the  licence. Health Canada wants to test a new regulatory approach that would use  a different method of risk management than requiring a licence amendment so that  the device can change its behaviour over time as it learns from new data it  acquires over time. The current project scope is limited to accessing the  legislative authorities to establish the sandbox and developing the sandbox  application scheme.
 
|Health Canada is developing a sandbox to test new regulatory approach for MLMDs. Currently, MLMD can be marketed in Canada if  the device algorithm behaviour is locked to remain the same overtime as what  was presented in the product’s market authorization application. Any change  to the algorithm behaviour requires the submission of an amendment to the  licence. Health Canada wants to test a new regulatory approach that would use  a different method of risk management than requiring a licence amendment so that  the device can change its behaviour over time as it learns from new data it  acquires over time. The current project scope is limited to accessing the  legislative authorities to establish the sandbox and developing the sandbox  application scheme.
 
|-
 
|-
151

edits

Navigation menu

GCwiki